A groundbreaking vitamin C treatment is showing such remarkable success in reducing sepsis mortality rates that some are branding it an outright miracle. A recent clinical study showed just how effective it can be. The researchers compared the outcome of 47 individuals who had sepsis. Some were treated with conventional medication, while others were given a combination of intravenous vitamin C, vitamin B1 (thiamine) and hydrocortisone.
Incredibly, the vitamin C treatment decreased mortality by 87 percent compared to those who got the standard therapy. A total of 47 patients received one of the two approaches, and 19 of the conventionally treated patients died versus just four of the vitamin C patients.
It’s a remarkably simple solution. It involves administering 1.5 grams of vitamin C intravenously every six hours for four days, along with 200 milligrams of thiamine every 12 hours for four days and 50 milligrams of hydrocortisone every six hours over the course of a week.
It’s believed that vitamin C neutralizes the high amounts of damaging reactive oxygen produced by the sepsis reaction. It also has the effect of suppressing inflammation, boosting circulation to the organs, and enhancing immunity. The hydrocortisone works alongside it to protect from capillary leakage.
The cost per patient is a mere $60, and it has no side effects.
Although this treatment can save lives, those who recover from sepsis still deal with its debilitating effects for months afterward. Two out of every five will end up returning to the hospital in their first three months after being discharged, and their risk of death remains raised for several years after the fact.
“Miracle juice” proving skeptical doctors wrong
One ICU nurse was amazed by how well it worked, saying she saw patient after patient go from being at death’s door to turning around within 24 to 48 hours. In fact, many healthcare providers are calling it “miracle juice.”
Low levels of vitamin C have been associated with sepsis. According to a study that was carried out last year, nearly all sepsis patients had low levels of vitamin C and 40 percent had deficiencies – even in cases where patients were getting a dosage of 125 milligrams per day of the vitamin. Unfortunately, illness can deplete vitamin C levels.
It’s been a long road for the man behind the treatment, Dr. Paul Marik. He said he experienced a lot of resistance at first. Because the claims are so outrageous, his approach was met with plenty of skepticism – until doctors starting seeing the results firsthand. Between 10 to 20 percent of intensive care specialists are already using the protocol, but he said that many are waiting for the results of further studies before getting fully on board.
However, if the results of the other research trials that are currently underway are as dramatic as believed, they could be called off early so more people will have access to this incredibly promising treatment for sepsis.
Sources for this article include:
Please contact us for more information.
